Provectus Pharmaceuticals Inc is certainly a company to watch very closely in the years ahead
PVCT 3 months chart:
stockcharts.com
Technical analysis:
stockta.com
Provectus Pharmaceuticals, Inc., a development-stage biopharmaceutical company, engages in the development, licensing, and marketing of over-the-counter (OTC) products, prescription drugs, and medical device systems. The company offers prescription drug products for the invasive treatment of chronic severe skin afflictions, such as psoriasis, eczema, and acne; and liver, breast, and prostate cancer. Its OTC products address markets primarily involving skincare applications, including hand irritation associated with use of disposable gloves, eczema, psoriasis, and mild to moderate acne. The company is also developing medical devices for cosmetic treatments, such as reduction of wrinkles and elimination of spider veins and other cosmetic blemishes, as well as for therapeutic uses, including photoactivation of its prescription drugs and nonsurgical destruction of certain skin cancers. Provectus Pharmaceuticals is based in Knoxville, Tennessee.
The Company's offices and laboratory are located at 7327 Oak Ridge Highway, Suite A, Knoxville, TN 37931; telephone: 865-769-4011. For more information, contact the Company at info@pvct.com or visit the corporate Web site: pvct.com .
PVCT News:
finance.yahoo.com
CEO interview (february 2005)
ceocfointerviews.com
financialnewsusa.com
PVCT Video CNBC Europe interview with CEO Craig Dees, Ph.D.
Decembre 23,2005
pvct.com
detailed research report:
pvct.com
PVCT insiders transactions:
secform4.com
Drug Delivery Technology magazine special feature article "Revisiting Intralesional Delivery of Cancer Treatment", by Provectus CEO Craig Dees, Ph.D., compares Provectus’ novel cancer drugs to current cancer treatments.
pvct.com |
